Hall V C, Wolf R E
Center of Excellence for Arthritis and Rheumatology, Louisiana State University Medical Center, Shreveport 71130, USA.
J Rheumatol. 1997 Aug;24(8):1467-70.
To assess the effects of tenidap, a new oxindole class antiinflammatory compound, on the proliferative response of cultured T cells to interleukin 2 (IL-2); and to compare these effects with the antiinflammatory drugs ibuprofen, naproxen, indomethacin, piroxicam, and sulindac.
T cells were cultured with either tenidap, ibuprofen, indomethacin, naproxen, piroxicam, or sulindac in the presence of IL-2, then assayed for incorporation of tritiated thymidine.
Tenidap, ibuprofen, and naproxen, at therapeutically attainable concentrations, significantly inhibited the proliferative response of T cells to IL-2. In contrast, indomethacin, piroxicam, and sulindac did not alter this response. Tenidap had a direct inhibitory effect on the response of activated T cells to IL-2. Both ibuprofen and naproxen interfered with the binding of IL-2 to T cells.
These results suggest variable effects of different antiinflammatory drugs on lymphocyte function that may relate to the differential effectiveness of these drugs in patients with rheumatoid arthritis.
评估新型异吲哚类抗炎化合物替硝唑对培养的T细胞对白介素2(IL-2)增殖反应的影响;并将这些影响与抗炎药物布洛芬、萘普生、吲哚美辛、吡罗昔康和舒林酸进行比较。
将T细胞与替硝唑、布洛芬、吲哚美辛、萘普生、吡罗昔康或舒林酸在IL-2存在的情况下进行培养,然后检测氚标记胸腺嘧啶核苷的掺入情况。
在可达到治疗浓度的情况下,替硝唑、布洛芬和萘普生显著抑制T细胞对IL-2的增殖反应。相比之下,吲哚美辛、吡罗昔康和舒林酸未改变这种反应。替硝唑对活化T细胞对IL-2的反应有直接抑制作用。布洛芬和萘普生均干扰IL-2与T细胞的结合。
这些结果表明不同抗炎药物对淋巴细胞功能的影响各异,这可能与这些药物在类风湿关节炎患者中的不同疗效有关。